Home › Markets › Health Care › PLYX

Polaryx Therapeutics Inc. (PLYX)

PLYX trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$1.94
-3.48% on the day
Market cap
$96.7M
Micro cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.

Profile

FieldValue
TickerPLYX on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0002075320
SEC industry codePharmaceutical Preparations
Incorporated inWY

Financials

Not reported in SEC XBRL data.

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
PROSPECTUS
424B42026-02-02
Latest annual report
ANNUAL REPORT
10-K2026-03-24
Latest quarterly / interim
QUARTERLY REPORT
10-Q2026-08-13
Latest current report
CURRENT REPORT
8-K2026-09-14
Latest proxy
DEFINITIVE ADDITIONAL MATERIALS
DEFA14A2026-07-28

Source: SEC EDGAR submissions feed, 35 recent filings. All filings on EDGAR.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
QUCYQuantum Cyber N.V.$1.12+8.74%$97.7M
MISTMilestone Pharmaceuticals Inc. Common Shares$0.7658-4.93%$95.3M
OKUROnKure Therapeutics Inc.$2.35-3.10%$95.0M
IMUXImmunic Inc.$6.89-13.33%$94.0M
ANIXAnixa Biosciences Inc.$2.67-5.99%$92.8M
CRBPCorbus Pharmaceuticals Holdings Inc.$4.78-9.30%$92.5M
PMVPPMV Pharmaceuticals Inc.$1.35-4.25%$101.9M
RTSNRetension Pharmaceuticals Inc.$11.63+2.74%$91.7M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier